Previous studies have already substantiated that the high expression of TOP2A was markedly related to poor OS and promotes early recurrence in patients with prostate cancer 59, endometrial cancer 60, non-muscle-invasive bladder cancer 61, and adrenocortical carcinoma 62. The gene discussed is TOP2A; the disease is prostate cancer.